Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 2 (2005), Issue 7 (July)

1. What is the microscopic tumor extent beyond clinically delineated gross tumor boundary in nonmelanoma skin cancers?
   Int J Radiat Oncol Biol Phys, 62(4): 1096-9. [Abstract] [Full-text]
2. Use of human tissue to assess the oncogenic activity of melanoma-associated mutations.
   Nat Genet, 37(7): 745-9. [Abstract] [Full-text]
3. Teratoma in human tail lipoma.
   Pediatr Neurosurg, 41(3): 158-61. [Abstract] [Full-text]
4. Predictors of self-reported confidence ratings for adult recall of early life sun exposure.
   Am J Epidemiol, 162(2): 183-92. [Abstract] [Full-text]
5. A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma.
   Blood, 106(2): 454-7. [Abstract] [Full-text]
6. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
   J Natl Cancer Inst, 97(13): 998-1007. [Abstract] [Full-text]
7. Contact dermatitis to quinoline, corticosteroids and antibiotics after short time treatment of delayed wound healing following malignant melanoma excision in a young woman.
   Skin Res Technol, 11(3): 218-9. [Abstract] [Full-text]
8. Non-invasive preoperative assessment of basal cell carcinoma of nodular and superficial types.
   Skin Res Technol, 11(3): 196-200. [Abstract] [Full-text]
9. Detection of asymmetric blotches (asymmetric structureless areas) in dermoscopy images of malignant melanoma using relative color.
   Skin Res Technol, 11(3): 179-84. [Abstract] [Full-text]
10. A systematic heuristic approach for feature selection for melanoma discrimination using clinical images.
    Skin Res Technol, 11(3): 165-78. [Abstract] [Full-text]
11. Transforming growth factor-beta1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system.
    Cancer Immunol Immunother, 54(9): 898-906. [Abstract] [Full-text]
12. Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium.
    Oncogene, 24(29): 4710-20. [Abstract] [Full-text]
13. Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration.
    Toxicol Sci, 86(2): 248-57. [Abstract] [Full-text]
14. Melanocytic matricoma in a dog.
    Vet Pathol, 42(4): 499-502. [Abstract] [Full-text]
15. Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors.
    Vet Pathol, 42(4): 437-45. [Abstract] [Full-text]
16. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
    J Clin Invest, 115(7): 1714-23. [Abstract] [Full-text]
17. Myxofibrosarcoma (myxoid malignant fibrous histiocytoma) showing cutaneous presentation: report of two cases.
    J Cutan Pathol, 32(7): 512-5. [Abstract] [Full-text]
18. Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
    J Cutan Pathol, 32(7): 491-5. [Abstract] [Full-text]
19. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
    J Cutan Pathol, 32(7): 474-83. [Abstract] [Full-text]
20. The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skin.
    J Cutan Pathol, 32(7): 467-73. [Abstract] [Full-text]
21. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation.
    Genes Chromosomes Cancer, 44(1): 10-8. [Abstract] [Full-text]
22. Immuno-gene therapy of melanoma by tumor antigen epitope modified IFN-gamma.
    Cancer Immunol Immunother, 54(8): 741-9. [Abstract] [Full-text]
23. Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia.
    Leuk Lymphoma, 46(7): 1051-5. [Abstract] [Full-text]
24. A case of peripheral T-cell lymphoma unspecified involving subcutaneous tissue.
    Leuk Lymphoma, 46(5): 785-8. [Abstract] [Full-text]
25. De novo CD5-positive diffuse large B-cell lymphoma of the skin arising in chronic limb lymphedema.
    Leuk Lymphoma, 46(5): 775-80. [Abstract] [Full-text]
26. Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphoma.
    Leuk Lymphoma, 46(5): 703-8. [Abstract] [Full-text]
27. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.
    Cancer Res, 65(14): 6034-41. [Abstract] [Full-text]
28. 8-Oxoguanine formation induced by chronic UVB exposure makes Ogg1 knockout mice susceptible to skin carcinogenesis.
    Cancer Res, 65(14): 6006-10. [Abstract] [Full-text]
29. The role of sentinel lymph node biopsy in the management of thin melanoma.
    Am J Surg, 190(2): 196-9. [Abstract] [Full-text]
30. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles.
    Int J Cancer, 116(4): 624-33. [Abstract] [Full-text]
31. Mycosis fungoides in European Russia: no antibodies to human T cell leukemia virus type I structural proteins, but virus-like sequences in blood and saliva.
    Intervirology, 48(6): 362-71. [Abstract] [Full-text]
32. No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years.
    Arch Dermatol, 141(7): 861-4. [Abstract] [Full-text]
33. Adrenal metastases of malignant melanoma: characteristic computed tomography appearances.
    Australas Radiol, 49(4): 325-9. [Abstract] [Full-text]
34. Role of dietary factors in the development of basal cell cancer and squamous cell cancer of the skin.
    Cancer Epidemiol Biomarkers Prev, 14(7): 1596-607. [Abstract] [Full-text]
35. Treatment of extensive scalp lesions with segmental intensity-modulated photon therapy.
    Int J Radiat Oncol Biol Phys, 62(5): 1549-58. [Abstract] [Full-text]
36. Combined effects of GSTP1 and MRP1 in melanoma drug resistance.
    Br J Cancer, 93(2): 216-23. [Abstract] [Full-text]
37. Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.
    J Clin Oncol, 23(21): 4764-70. [Abstract] [Full-text]
38. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database.
    J Clin Oncol, 23(21): 4735-41. [Abstract] [Full-text]
39. Fatty acid synthase expression in cutaneous melanocytic neoplasms.
    Mod Pathol, 18(8): 1107-12. [Abstract] [Full-text]
40. Melanocytic lesions associated with dermatofibromas: a spectrum of lesions ranging from junctional nevus to malignant melanoma in situ.
    Mod Pathol, 18(8): 1043-7. [Abstract] [Full-text]
41. Merkel cells, normal and neoplastic: an update.
    Ultrastruct Pathol, 29(3): 287-94. [Abstract] [Full-text]
42. Gene mutation analysis in five cases of dermatofibrosarcoma protuberans using formalin-fixed, paraffin-embedded tissues.
    Acta Derm Venereol, 85(3): 221-4. [Abstract] [Full-text]
43. Cross-sectional imaging in non-melanoma skin cancer of the head and neck.
    Clin Radiol, 60(8): 869-77. [Abstract] [Full-text]
44. The role of trivalent dimethylated arsenic in dimethylarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress.
    Toxicol Lett, 158(2): 87-94. [Abstract] [Full-text]
45. The perimeter technique for lentigo maligna: an alternative to Mohs micrographic surgery.
    J Surg Oncol, 91(2): 120-5. [Abstract] [Full-text]
46. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
    J Surg Oncol, 91(2): 107-11. [Abstract] [Full-text]
47. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Cancer, 104(3): 570-9. [Abstract] [Full-text]
48. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
    Mol Carcinog, 43(4): 198-206. [Abstract] [Full-text]
49. Interventional study in 1,232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behavior.
    Int J Cancer, 116(5): 755-61. [Abstract] [Full-text]
50. Dermal non-neural granular cell tumour (so-called primitive polypoid granular cell tumour): a distinctive entity further delineated in a clinicopathological study of 11 cases.
    Histopathology, 47(2): 179-85. [Abstract] [Full-text]
51. Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients.
    J Clin Oncol, 23(22): 5088-93. [Abstract] [Full-text]
52. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
    J Vet Med A Physiol Pathol Clin Med, 52(6): 280-6. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.